Article info

Download PDFPDF

Indolent peritoneal mesothelioma: PI3K-mTOR inhibitors as a novel therapeutic strategy

Authors

  1. Correspondence to Dr Susana Banerjee; Susana.Banerjee{at}rmh.nhs.uk
View Full Text

Citation

Dolly SO, Migali C, Tunariu N, et al
Indolent peritoneal mesothelioma: PI3K-mTOR inhibitors as a novel therapeutic strategy

Publication history

  • Received August 27, 2016
  • Accepted September 5, 2016
  • First published April 12, 2017.
Online issue publication 
April 12, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.